Our previous work has demonstrated that the non-structural protein 1 (NS1) of influenza A virus is an accessory virulent factor implicated in the attenuation of the type I interferon (IFN) response of the host during viral infection. This is mainly achieved by the N-terminal dsRNA-binding region of the NS1 that prevents the induction of IRF-3, a key cellular transcription factor that when activated stimulates the IFN-beta promoter. Our recent results indicate that the NS1 of influenza B virus (less than 25% amino acid identity with the NS1 of influenza A virus) also prevents the induction of IRF-3 but in this case this is achieved by the concerted action of the N-terminal dsRNA-binding and the C-terminal non-dsRNA-binding regions. We are now planning to investigate at the molecular level the mechanism of action by which the NS1 proteins of influenza A and B viruses inhibit the activation of IRF-3 and antagonize the IFN response. Our preliminary data strongly suggest that sequestration of viral dsRNA by the NS1, a potent activator of IFN synthesis, is not entirely responsible for the IFN antagonism of these proteins, and identify two cellular RNA helicases as potential cellular targets for the influenza A virus NS1. Both of these RNA helicases, RIG-I and MDA-5, have recently been implicated in the induction of IFN through its ability to """"""""sense"""""""" dsRNA and transmit an activation signal that results in IRF-3 phosphorylation. We will now investigate the role that these cellular RNA helicases play on the IFN antagonist function of the NS1 of influenza A virus and on modulation of virulence. In addition, we have designed experiments to understand the similarities and differences between the NS1 proteins of influenza A and B viruses with respect to their ability to inhibit the IFN response and to promote viral replication in the host. Our proposed experiments will generate novel information that not only will increase our knowledge on how influenza viruses disarm the antiviral IFN response, but that will also contribute to a better understanding on the role that cellular RNA helicases play in the initiation of the IFN response. Since the NS1 proteins are one of the determinants of virulence of influenza viruses, our proposal falls under one of the High-Priority Influenza Research Areas of the NIAID Biodefense Research Program: Determination of molecular basis of virulence of influenza viruses. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI046954-06A1
Application #
7101443
Study Section
Virology - B Study Section (VIRB)
Program Officer
Lacourciere, Karen A
Project Start
1999-12-01
Project End
2011-01-31
Budget Start
2006-02-01
Budget End
2007-01-31
Support Year
6
Fiscal Year
2006
Total Cost
$339,000
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Ayllon, Juan; Domingues, Patricia; Rajsbaum, Ricardo et al. (2014) A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence. J Virol 88:12146-51
Rajsbaum, Ricardo; García-Sastre, Adolfo; Versteeg, Gijs A (2014) TRIMmunity: the roles of the TRIM E3-ubiquitin ligase family in innate antiviral immunity. J Mol Biol 426:1265-84
Tsai, Pei-Ling; Chiou, Ni-Ting; Kuss, Sharon et al. (2013) Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. PLoS Pathog 9:e1003460
Perez, Jasmine T; García-Sastre, Adolfo; Manicassamy, Balaji (2013) Insertion of a GFP reporter gene in influenza virus. Curr Protoc Microbiol Chapter 15:Unit 15G.4
Weber, Michaela; Gawanbacht, Ali; Habjan, Matthias et al. (2013) Incoming RNA virus nucleocapsids containing a 5'-triphosphorylated genome activate RIG-I and antiviral signaling. Cell Host Microbe 13:336-46
Ramos, Irene; Carnero, Elena; Bernal-Rubio, Dabeiba et al. (2013) Contribution of double-stranded RNA and CPSF30 binding domains of influenza virus NS1 to the inhibition of type I interferon production and activation of human dendritic cells. J Virol 87:2430-40
Rajsbaum, Ricardo; García-Sastre, Adolfo (2013) Viral evasion mechanisms of early antiviral responses involving regulation of ubiquitin pathways. Trends Microbiol 21:421-9
Ayllon, Juan; Russell, Rupert J; García-Sastre, Adolfo et al. (2012) Contribution of NS1 effector domain dimerization to influenza A virus replication and virulence. J Virol 86:13095-8
Marazzi, Ivan; Ho, Jessica S Y; Kim, Jaehoon et al. (2012) Suppression of the antiviral response by an influenza histone mimic. Nature 483:428-33
Rajsbaum, Ricardo; Albrecht, Randy A; Wang, May K et al. (2012) Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog 8:e1003059

Showing the most recent 10 out of 69 publications